Evaluation of an integrated care program for schizophrenia: concept and study design

Area of Science:

• Psychiatry and Health Services Research
• Comparative Effectiveness Research
• Health Economics

Background:

• Schizophrenia care in Germany involves diverse treatment pathways.
• Integrated care models aim to improve patient outcomes and resource utilization.
• A need exists for rigorous evaluation of integrated care's effectiveness and efficiency.

Purpose of the Study:

• To design and conduct an independent scientific evaluation of different care pathways for schizophrenia patients in Germany.
• To compare the effectiveness and efficiency of integrated care versus routine care.
• To assess impact on psychiatric hospital days, readmissions, symptom severity, remission, and quality of life.

Main Methods:

• Prospective, observational study design with three groups: integrated care (IG), routine care (CG 1), and non-participating psychiatrists (CG 2).
• Primary outcome: total psychiatric hospital days at 12 months.
• Secondary outcomes: readmission frequency, symptom severity, remission rates, quality of life, cost-effectiveness, and cost-utility analysis using questionnaires and health insurance data.

Main Results:

• Currently, 137 psychiatrists have enrolled 980 patients in the integrated care project.
• 47 psychiatrists are participating in the independent evaluation across all groups.
• The study is initiating a countrywide evaluation of integrated care for schizophrenia, recruiting 500 patients.

Conclusions:

• This study represents the first prospective, controlled evaluation of a countrywide integrated care project for schizophrenia in Germany.
• Comprehensive assessments and routine data will provide robust evidence on integrated care's impact.
• Findings will inform healthcare policy and practice regarding schizophrenia management.